South Korea begins plasma treatment trial for Mers
South Korea is to begin trials of an experimental plasma treatment for Middle East Respiratory Syndrome (Mers), which has now killed 19 people.
The treatment, which has already proved useful for tackling other deadly diseases, including Ebola, uses blood from patients who have successfully fought off the same infection.
To date, more than 150 people in the country have been infected with Mers.Also on Tuesday, Germany reported its first death from the disease.
The South Korean health ministry said two hospitals would begin the plasma treatment trials.
The outbreak in South Korea originated from a 68-year-old man who had travelled to the Middle East. He was diagnosed as the country's first Mers patient last month.
Health workers are spraying disinfectant inside karaoke rooms and other businesses, and teachers are sprinkling salt on school grounds in a misplaced attempt to protect themselves as many schools reopen this week.
Related Posts